John M. Bedtelyon

Array ( [id] => 8141047 [patent_doc_number] => 20120095080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'METHODS FOR PRODUCING INTERFERING RNA MOLECULES IN MAMMALIAN CELLS AND THERAPEUTIC USES FOR SUCH MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/324104 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7741 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095080.pdf [firstpage_image] =>[orig_patent_app_number] => 13324104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9004526 [patent_doc_number] => 20130225651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'siRNA Compositions and Methods for Potently Inhibiting Viral Infection' [patent_app_type] => utility [patent_app_number] => 13/323364 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 19342 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9175102 [patent_doc_number] => 20130317088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Selective Reduction of the Deleterious Activity of Extended Tri-Nucleotide Repeat Containing Genes' [patent_app_type] => utility [patent_app_number] => 13/988605 [patent_app_country] => US [patent_app_date] => 2011-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19441 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933109 [patent_doc_number] => 20140336130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS' [patent_app_type] => utility [patent_app_number] => 14/362559 [patent_app_country] => US [patent_app_date] => 2011-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 31512 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14362559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9440913 [patent_doc_number] => 08710023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Antisense modulation of C-reactive protein expression' [patent_app_type] => utility [patent_app_number] => 13/309835 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8834536 [patent_doc_number] => 08450292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating B cell neoplasm' [patent_app_type] => utility [patent_app_number] => 13/310595 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6979 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13310595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8324516 [patent_doc_number] => 20120196920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES AGAINST ACETYLCHOLINESTERASE FOR TREATING INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 13/306356 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9031 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10083726 [patent_doc_number] => 09121066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome' [patent_app_type] => utility [patent_app_number] => 13/989423 [patent_app_country] => US [patent_app_date] => 2011-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 10183 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490172 [patent_doc_number] => 20120289579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'IMPAIRED WOUND HEALING COMPOSITIONS AND TREATMENTS' [patent_app_type] => utility [patent_app_number] => 13/295020 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22010 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13295020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186897 [patent_doc_number] => 20120115930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'COMPOSITIONS AND THEIR USES DIRECTED TO HEPCIDIN' [patent_app_type] => utility [patent_app_number] => 13/294068 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16442 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115930.pdf [firstpage_image] =>[orig_patent_app_number] => 13294068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122172 [patent_doc_number] => 20130289094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Compositions and Methods for Inhibition of PCSK9 Genes' [patent_app_type] => utility [patent_app_number] => 13/882473 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 52724 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703899 [patent_doc_number] => 08828961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Methods and compositions to protect aquatic invertebrates from disease' [patent_app_type] => utility [patent_app_number] => 13/277066 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 35728 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13277066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122336 [patent_doc_number] => 20130289258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'METHODS OF INDUCING INSULIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 13/877968 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28849 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241164 [patent_doc_number] => 20120149893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'MODULATION OF EIF4E-BP2' [patent_app_type] => utility [patent_app_number] => 13/267805 [patent_app_country] => US [patent_app_date] => 2011-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24030 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13267805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744649 [patent_doc_number] => 20120022140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel' [patent_app_type] => utility [patent_app_number] => 13/246890 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4787 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022140.pdf [firstpage_image] =>[orig_patent_app_number] => 13246890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003057 [patent_doc_number] => 20130224182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/247882 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21787 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13247882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733237 [patent_doc_number] => 20120015850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'siRNA targeting Superoxide' [patent_app_type] => utility [patent_app_number] => 13/199946 [patent_app_country] => US [patent_app_date] => 2011-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34529 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015850.pdf [firstpage_image] =>[orig_patent_app_number] => 13199946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676910 [patent_doc_number] => 08815819 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Anti-connexin compounds targeted to connexins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 13/230744 [patent_app_country] => US [patent_app_date] => 2011-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 17 [patent_no_of_words] => 38816 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13230744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10039236 [patent_doc_number] => 09079934 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-14 [patent_title] => 'Antisense nucleic acids' [patent_app_type] => utility [patent_app_number] => 13/819520 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18248 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090467 [patent_doc_number] => 09127280 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient' [patent_app_type] => utility [patent_app_number] => 13/819722 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 34 [patent_no_of_words] => 18803 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 183 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13819722 [rel_patent_id] =>[rel_patent_doc_number] =>)